ViroPharma Loses Bid To Block Generic Vancocin
ViroPharma Inc. lost a bid to temporarily block the U.S. Food and Drug Administration's recent approval of generic versions of the antibiotic Vancocin after a Washington federal judge ruled Monday that...To view the full article, register now.
Already a subscriber? Click here to view full article